» Articles » PMID: 25365510

Activation of MiR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene

Overview
Journal PLoS One
Date 2014 Nov 4
PMID 25365510
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The present study is to investigate the role of microRNA-21 (miR-21) in nasopharyngeal carcinoma (NPC) and the mechanisms of regulation of PTEN by miR-21. Fifty-four tissue samples were collected from 42 patients with NPC and 12 healthy controls. Human NPC cell lines CNE-1, CNE-2, TWO3 and C666-1 were used for cell assays. To investigate the expression of miR-21, RT-PCR was employed. RT-PCR, Western blotting, and immunohistochemistry were used to measure the expression of STAT3 mRNA and STAT3 protein. To test the effect of miR-21 on the cell growth and apoptosis of NPC cells in vitro, transfection of CNE1 and CNE2 cell lines and flow cytometry were performed. TUNEL assay was used to detect DNA fragmentation. To validate whether miR-21 directly recognizes the 3'-UTRs of PTEN mRNA, luciferase reporter assay was employed. miR-21 expression was increased in NPC tissues compared with control and the same result was found in NPC cell lines. Notably, increased expression of miR-21 was directly related to advanced clinical stage and lymph node metastasis. STAT3, a transcription factor activated by IL-6, directly activated miR-21 in transformed NPC cell lines. Furthermore, miR-21 markedly inhibited PTEN tumor suppressor, leading to increased AKT activity. Both in vitro and in vivo assays revealed that miR-21 enhanced NPC cell proliferation and suppressed apoptosis. miR-21, activated by STAT3, induced proliferation and suppressed apoptosis in NPC by targeting PTEN-AKT pathway.

Citing Articles

Mechanisms of apoptosis-related non-coding RNAs in ovarian cancer: a narrative review.

Wang Y, Wang S, He H, Bai Y, Liu Z, Sabihi S Apoptosis. 2025; .

PMID: 39833637 DOI: 10.1007/s10495-024-02074-w.


Evaluation of Xihuang Pill in inducing pyroptosis in glioma cells through modulation of miR-21-5p.

Tang N, Geng N, Zhu X 3 Biotech. 2024; 14(12):295.

PMID: 39529806 PMC: 11550298. DOI: 10.1007/s13205-024-04148-7.


Progress in Precision Medicine for Head and Neck Cancer.

Vakili S, Behrooz A, Whichelo R, Fernandes A, Emwas A, Jaremko M Cancers (Basel). 2024; 16(21).

PMID: 39518152 PMC: 11544984. DOI: 10.3390/cancers16213716.


MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.

Chen Y, Lin T, Tang L, He L, He Y Am J Cancer Res. 2024; 13(12):5805-5824.

PMID: 38187072 PMC: 10767356.


miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology.

Kozlowska-Maslon J, Guglas K, Kolenda T, Lamperska K, Makalowska I Rep Pract Oncol Radiother. 2024; 28(5):681-697.

PMID: 38179293 PMC: 10764040. DOI: 10.5603/rpor.96666.


References
1.
Chern C, Beutler E . Biochemical and electrophoretic studies of erythrocyte pyridoxine kinase in white and black Americans. Am J Hum Genet. 1976; 28(1):9-17. PMC: 1684914. View

2.
Vogt P, Gymnopoulos M, Hart J . PI 3-kinase and cancer: changing accents. Curr Opin Genet Dev. 2009; 19(1):12-7. PMC: 2746202. DOI: 10.1016/j.gde.2008.11.011. View

3.
Yan L, Huang X, Shao Q, Huang M, Deng L, Wu Q . MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008; 14(11):2348-60. PMC: 2578865. DOI: 10.1261/rna.1034808. View

4.
Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y . miR-21-mediated tumor growth. Oncogene. 2006; 26(19):2799-803. DOI: 10.1038/sj.onc.1210083. View

5.
Wu L, Li Z, Zhang Y, Zhang P, Zhu X, Huang J . Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells. Mol Cancer Ther. 2008; 7(1):222-32. DOI: 10.1158/1535-7163.MCT-07-0382. View